Fig. 3From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways a Prohibtin expression in benign papillary serous cystadenoma. (IHC; ×40). b Prohibitin expression in benign mucinous cystadenoma.(IHC; ×40)Back to article page